Stockreport

Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK™ (sodium thiosulfate) Presented at the 49th Congress of the International Society of Pediatric Oncology (SIOP) 2017...

Fennec Pharmaceuticals Inc.  (FENC) 
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.fennecpharma.com/investor-relations
PDF Study met primary endpoint (p=0.0033) Significant reduction in cisplatin induced hearing loss without any evidence of tumour protection in patients with Standard Risk He [Read more]